@article{a97a53f57da349398e6fa1bf6da0fc43,
title = "Cancer detection during the COVID-19 pandemic-Experiences in primary care and recommendations for the future",
abstract = "Background: To describe general practitioners (GPs) experiences with the impact COVID-19 on the duration of cancer detection.Methods: Cross-sectional survey study among Dutch GPs.Results: Fifty-eight GPs participated. During the first wave, COVID-19-related delays were experienced by 88%, 52%, and 67% of GPs in the contact-seeking, primary care, and referral phases, respectively. GPs reported delays due to telehealth consultations, longer waiting times and patient's concerns of COVID infections and overburdening GPs.Conclusions: The majority of GPs experienced delays in cancer diagnostic processes during the beginning of the COVID pandemic, which was most prominent in the timeliness in which patients sought GP care.",
keywords = "cancer, cancer diagnosis, COVID, family medicine, primary care",
author = "{Van den Berg}, M.F.R.S. and M. Grant and {van Erp}, N. and {van Gils}, C.H. and J. Muris and D. Brandenbarg and {van Asselt}, K.M. and {de Wit}, N.J. and C.W. Helsper",
note = "Funding Information: This work was supported by the ZonMW [grant number 10430022010014]. The funding sources had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report, and in the decision to submit the article for publication. Funding Information: We thank all GPs participating in the survey study and Otto Maarsingh of Amsterdam UMC location Vrije Universiteit, Department of General Practice, Amsterdam, the Netherlands, for his role in the development of the survey. The authors acknowledge the members of the COVID and Cancer-NL Consortium: Prof. dr. S. Siesling Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht and Technical Medical Centre, Department of Health Technology and Services Research, Twente University, Enschede; Dr. J.C. van Hoeve, Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht; prof. dr. M.A.W. Merkx, Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht; Department of Oral and Maxillofacial Surgery, Radboud University Nijmegen Medical Centre, Nijmegen; Prof. Dr. N.J. de Wit, Department of General Practice, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht (UMCU), Utrecht University, Utrecht; Dr. C.W. Helsper, Department of General Practice, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht (UMCU), Utrecht University, Utrecht; M.Sc. I. Dingemans, Dutch Federation of Cancer Patient Organisations (NFK), Utrecht; Prof. Dr. I.D. Nagtegaal, Department of Pathology, Radboud University Nijmegen Medical Centre, Nijmegen, on behalf of the Automated Pathology Archive (PALGA); Drs. M. van der Schaaf Department of Insight and Innovation, Dutch Hospital Data (DHD), Utrecht; Prof. Dr. C.H. van Gils Department of Clinical Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht (UMCU), Utrecht University, Utrecht; Prof. Dr. H.C.P.M. van Weert, Department of General Practice, Amsterdam Public Health, Amsterdam UMC location AMC, Amsterdam; Prof. Dr. M. Verheij, Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, on behalf of SONCOS (Dutch Multidisciplinary Oncology Foundation); all in The Netherlands. Publisher Copyright: {\textcopyright} 2022 The Authors. Journal of General and Family Medicine published by John Wiley & Sons Australia, Ltd on behalf of Japan Primary Care Association.",
year = "2023",
month = mar,
doi = "10.1002/jgf2.597",
language = "English",
volume = "24",
pages = "131--134",
journal = "Journal of General and Family Medicine",
issn = "2189-6577",
publisher = "Wiley-Blackwell",
number = "2",
}